You are here: Industry Insights > prostate

News List

Prostate Cancer Risk Higher in Men Receiving Fertility Treatment drugs
September 27, 2019
Men fathering children through assisted reproduction techniques rather than natural conception have an increased risk for prostate cancer, including early-onset disease, according to a study published online in The BMJ.
Doubt Over Long-Term Use of Hormone Rx for Recurrent Prostate Cancer drugs
September 18, 2019
Running contrary to current guidelines, new research suggests that use of hormone-suppressing treatment over the long term may not help some men battling recurrent prostate cancer, and may even cause harm.
XTANDI® treatment granted priority review by FDA europeanpharmaceuticalreview
August 27, 2019
XTANDI® sNDA seeks to add an indication for men with prostate cancer that’s spread but is sensitive to hormone therapy.
Comorbid CVD May Up Mortality With ADT for Prostate Cancer drugs
August 14, 2019
Elderly prostate cancer patients with preexisting cardiovascular diseases (CVDs) using abiraterone acetate (AA) or enzalutamide (ENZ) have higher short-term mortality compared with their counterparts without CVDs...
Adjuvant RT May Cut Recurrence in Some With Prostate Cancer drugs
August 13, 2019
Adjuvant radiotherapy after radical prostatectomy compared with surgery alone may prolong biochemical recurrence-free survival in patients with locally advanced prostate cancer...
Worse Cancer Outcomes for Elderly HIV-Infected Patients drugs
August 12, 2019
Elderly HIV-infected patients with cancer have worse outcomes than HIV-uninfected patients with cancer, according to a study published online in JAMA Oncology.
Common Prostate Cancer Treatment Anti-Androgens May Increase Risk of Fatal Heart Condition drugs
August 06, 2019
Many men with prostate cancer rely on common testosterone-blocking drugs as a part of their treatment.
FDA Approves Nubeqa (darolutamide) for Men with Non-Metastatic Castration-Resistant Prostate Cancer drugs
August 01, 2019
The U.S. Food and Drug Administration (FDA) today approved Nubeqa® (darolutamide), an androgen receptor inhibitor (ARi)...
Hormone Treatment for Prostate Cancer Linked to Heightened Alzheimer's Risk drugs
July 09, 2019
Soon after a man is diagnosed with prostate cancer, drugs that lower levels of testosterone are often offered as treatment, since testosterone fuels the cancer's growth.
Urine Biomarker Helps Classify Risk Level in Prostate Cancer drugs
July 04, 2019
Urine Biomarker Helps Classify Risk Level in Prostate Cancer.

Previous page 1 2 3 Next page